Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 9 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AT63
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.523 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.734 |
DOC_CKS1_1 | 149 | 154 | PF01111 | 0.433 |
DOC_CKS1_1 | 33 | 38 | PF01111 | 0.595 |
DOC_CYCLIN_RxL_1 | 80 | 89 | PF00134 | 0.355 |
DOC_PP1_RVXF_1 | 96 | 102 | PF00149 | 0.513 |
DOC_PP2B_LxvP_1 | 181 | 184 | PF13499 | 0.435 |
DOC_PP4_FxxP_1 | 2 | 5 | PF00568 | 0.653 |
DOC_PP4_FxxP_1 | 249 | 252 | PF00568 | 0.452 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.755 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.641 |
DOC_USP7_MATH_1 | 138 | 142 | PF00917 | 0.650 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.607 |
DOC_WW_Pin1_4 | 148 | 153 | PF00397 | 0.442 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.669 |
DOC_WW_Pin1_4 | 32 | 37 | PF00397 | 0.530 |
LIG_14-3-3_CanoR_1 | 15 | 23 | PF00244 | 0.596 |
LIG_14-3-3_CanoR_1 | 91 | 99 | PF00244 | 0.444 |
LIG_BRCT_BRCA1_1 | 165 | 169 | PF00533 | 0.532 |
LIG_BRCT_BRCA1_1 | 40 | 44 | PF00533 | 0.448 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.447 |
LIG_FHA_1 | 163 | 169 | PF00498 | 0.379 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.418 |
LIG_LIR_Gen_1 | 158 | 168 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 154 | 160 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.472 |
LIG_LIR_Nem_3 | 224 | 229 | PF02991 | 0.442 |
LIG_LIR_Nem_3 | 67 | 73 | PF02991 | 0.475 |
LIG_LYPXL_S_1 | 225 | 229 | PF13949 | 0.432 |
LIG_LYPXL_SIV_4 | 69 | 77 | PF13949 | 0.478 |
LIG_LYPXL_yS_3 | 226 | 229 | PF13949 | 0.432 |
LIG_Pex14_2 | 178 | 182 | PF04695 | 0.486 |
LIG_PTB_Apo_2 | 112 | 119 | PF02174 | 0.551 |
LIG_PTB_Apo_2 | 203 | 210 | PF02174 | 0.333 |
LIG_PTB_Phospho_1 | 203 | 209 | PF10480 | 0.359 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.440 |
LIG_SH2_GRB2like | 107 | 110 | PF00017 | 0.378 |
LIG_SH2_SRC | 31 | 34 | PF00017 | 0.552 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.563 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.453 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.565 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.421 |
LIG_SH3_2 | 150 | 155 | PF14604 | 0.593 |
LIG_SH3_3 | 146 | 152 | PF00018 | 0.558 |
LIG_SH3_3 | 27 | 33 | PF00018 | 0.636 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.660 |
LIG_SH3_3 | 66 | 72 | PF00018 | 0.495 |
LIG_TYR_ITIM | 68 | 73 | PF00017 | 0.523 |
LIG_TYR_ITSM | 222 | 229 | PF00017 | 0.445 |
LIG_UBA3_1 | 1 | 9 | PF00899 | 0.728 |
LIG_WRC_WIRS_1 | 189 | 194 | PF05994 | 0.414 |
MOD_CDK_SPxxK_3 | 148 | 155 | PF00069 | 0.430 |
MOD_CK1_1 | 240 | 246 | PF00069 | 0.569 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.469 |
MOD_CK2_1 | 105 | 111 | PF00069 | 0.473 |
MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.429 |
MOD_GlcNHglycan | 215 | 220 | PF01048 | 0.570 |
MOD_GlcNHglycan | 231 | 234 | PF01048 | 0.397 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.497 |
MOD_GSK3_1 | 10 | 17 | PF00069 | 0.755 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.360 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.540 |
MOD_N-GLC_1 | 237 | 242 | PF02516 | 0.581 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.463 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.470 |
MOD_NEK2_1 | 163 | 168 | PF00069 | 0.507 |
MOD_NEK2_2 | 51 | 56 | PF00069 | 0.554 |
MOD_PIKK_1 | 16 | 22 | PF00454 | 0.598 |
MOD_PK_1 | 56 | 62 | PF00069 | 0.508 |
MOD_PKA_2 | 14 | 20 | PF00069 | 0.717 |
MOD_Plk_1 | 237 | 243 | PF00069 | 0.629 |
MOD_Plk_1 | 94 | 100 | PF00069 | 0.473 |
MOD_Plk_4 | 138 | 144 | PF00069 | 0.573 |
MOD_Plk_4 | 174 | 180 | PF00069 | 0.528 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.444 |
MOD_Plk_4 | 221 | 227 | PF00069 | 0.416 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.531 |
MOD_ProDKin_1 | 148 | 154 | PF00069 | 0.433 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.661 |
TRG_DiLeu_BaLyEn_6 | 128 | 133 | PF01217 | 0.418 |
TRG_ENDOCYTIC_2 | 160 | 163 | PF00928 | 0.491 |
TRG_ENDOCYTIC_2 | 209 | 212 | PF00928 | 0.408 |
TRG_ENDOCYTIC_2 | 226 | 229 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.435 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCH2 | Leptomonas seymouri | 67% | 100% |
A0A0S4IV73 | Bodo saltans | 35% | 100% |
A0A1X0NKA4 | Trypanosomatidae | 44% | 100% |
A0A3R7L2T5 | Trypanosoma rangeli | 37% | 100% |
A0A3S7XB21 | Leishmania donovani | 91% | 100% |
A4HPF2 | Leishmania braziliensis | 75% | 100% |
A4ICJ3 | Leishmania infantum | 91% | 100% |
D0A3G4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
Q4Q1D4 | Leishmania major | 88% | 100% |